Cargando…

A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophrenia

BACKGROUND: Antipsychotic medications often have a variety of side effects, however, it is not well understood how the presence of specific side effects correlate with adherence in a real-world setting. The aim of the current study was to examine the relationship between these variables among commun...

Descripción completa

Detalles Bibliográficos
Autores principales: DiBonaventura, Marco, Gabriel, Susan, Dupclay, Leon, Gupta, Shaloo, Kim, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342101/
https://www.ncbi.nlm.nih.gov/pubmed/22433036
http://dx.doi.org/10.1186/1471-244X-12-20
_version_ 1782231630244478976
author DiBonaventura, Marco
Gabriel, Susan
Dupclay, Leon
Gupta, Shaloo
Kim, Edward
author_facet DiBonaventura, Marco
Gabriel, Susan
Dupclay, Leon
Gupta, Shaloo
Kim, Edward
author_sort DiBonaventura, Marco
collection PubMed
description BACKGROUND: Antipsychotic medications often have a variety of side effects, however, it is not well understood how the presence of specific side effects correlate with adherence in a real-world setting. The aim of the current study was to examine the relationship between these variables among community-dwelling patients with schizophrenia. METHODS: Data were analyzed from a 2007-2008 nationwide survey of adults who self-reported a diagnosis of schizophrenia and were currently using an antipsychotic medication (N = 876). The presence of side effects was defined as those in which the patient reported they were at least "somewhat bothered". Adherence was defined as a score of zero on the Morisky Medication Adherence Scale. To assess the relationship between side effects and adherence, individual logistic regression models were fitted for each side effect controlling for patient characteristics. A single logistic regression model assessed the relationship between side effect clusters and adherence. The relationships between adherence and health resource use were also examined. RESULTS: A majority of patients reported experiencing at least one side effect due to their medication (86.19%). Only 42.5% reported complete adherence. Most side effects were associated with a significantly reduced likelihood of adherence. When grouped as side effect clusters in a single model, extra pyramidal symptoms (EPS)/agitation (odds ratio (OR) = 0.57, p = 0.0007), sedation/cognition (OR = 0.70, p = 0.033), prolactin/endocrine (OR = 0.69, p = 0.0342), and metabolic side effects (OR = 0.64, p = 0.0079) were all significantly related with lower rates of adherence. Those who reported complete adherence to their medication were significantly less likely to report a hospitalization for a mental health reason (OR = 0.51, p = 0.0006), a hospitalization for a non-mental health reason (OR = 0.43, p = 0.0002), and an emergency room (ER) visit for a mental health reason (OR = 0.60, p = 0.008). CONCLUSIONS: Among patients with schizophrenia, medication side effects are highly prevalent and significantly associated with medication nonadherence. Nonadherence is significantly associated with increased healthcare resource use. Prevention, identification, and effective management of medication-induced side effects are important to maximize adherence and reduce health resource use in schizophrenia.
format Online
Article
Text
id pubmed-3342101
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33421012012-05-03 A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophrenia DiBonaventura, Marco Gabriel, Susan Dupclay, Leon Gupta, Shaloo Kim, Edward BMC Psychiatry Research Article BACKGROUND: Antipsychotic medications often have a variety of side effects, however, it is not well understood how the presence of specific side effects correlate with adherence in a real-world setting. The aim of the current study was to examine the relationship between these variables among community-dwelling patients with schizophrenia. METHODS: Data were analyzed from a 2007-2008 nationwide survey of adults who self-reported a diagnosis of schizophrenia and were currently using an antipsychotic medication (N = 876). The presence of side effects was defined as those in which the patient reported they were at least "somewhat bothered". Adherence was defined as a score of zero on the Morisky Medication Adherence Scale. To assess the relationship between side effects and adherence, individual logistic regression models were fitted for each side effect controlling for patient characteristics. A single logistic regression model assessed the relationship between side effect clusters and adherence. The relationships between adherence and health resource use were also examined. RESULTS: A majority of patients reported experiencing at least one side effect due to their medication (86.19%). Only 42.5% reported complete adherence. Most side effects were associated with a significantly reduced likelihood of adherence. When grouped as side effect clusters in a single model, extra pyramidal symptoms (EPS)/agitation (odds ratio (OR) = 0.57, p = 0.0007), sedation/cognition (OR = 0.70, p = 0.033), prolactin/endocrine (OR = 0.69, p = 0.0342), and metabolic side effects (OR = 0.64, p = 0.0079) were all significantly related with lower rates of adherence. Those who reported complete adherence to their medication were significantly less likely to report a hospitalization for a mental health reason (OR = 0.51, p = 0.0006), a hospitalization for a non-mental health reason (OR = 0.43, p = 0.0002), and an emergency room (ER) visit for a mental health reason (OR = 0.60, p = 0.008). CONCLUSIONS: Among patients with schizophrenia, medication side effects are highly prevalent and significantly associated with medication nonadherence. Nonadherence is significantly associated with increased healthcare resource use. Prevention, identification, and effective management of medication-induced side effects are important to maximize adherence and reduce health resource use in schizophrenia. BioMed Central 2012-03-20 /pmc/articles/PMC3342101/ /pubmed/22433036 http://dx.doi.org/10.1186/1471-244X-12-20 Text en Copyright ©2012 DiBonaventura et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
DiBonaventura, Marco
Gabriel, Susan
Dupclay, Leon
Gupta, Shaloo
Kim, Edward
A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophrenia
title A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophrenia
title_full A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophrenia
title_fullStr A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophrenia
title_full_unstemmed A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophrenia
title_short A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophrenia
title_sort patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophrenia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342101/
https://www.ncbi.nlm.nih.gov/pubmed/22433036
http://dx.doi.org/10.1186/1471-244X-12-20
work_keys_str_mv AT dibonaventuramarco apatientperspectiveoftheimpactofmedicationsideeffectsonadherenceresultsofacrosssectionalnationwidesurveyofpatientswithschizophrenia
AT gabrielsusan apatientperspectiveoftheimpactofmedicationsideeffectsonadherenceresultsofacrosssectionalnationwidesurveyofpatientswithschizophrenia
AT dupclayleon apatientperspectiveoftheimpactofmedicationsideeffectsonadherenceresultsofacrosssectionalnationwidesurveyofpatientswithschizophrenia
AT guptashaloo apatientperspectiveoftheimpactofmedicationsideeffectsonadherenceresultsofacrosssectionalnationwidesurveyofpatientswithschizophrenia
AT kimedward apatientperspectiveoftheimpactofmedicationsideeffectsonadherenceresultsofacrosssectionalnationwidesurveyofpatientswithschizophrenia
AT dibonaventuramarco patientperspectiveoftheimpactofmedicationsideeffectsonadherenceresultsofacrosssectionalnationwidesurveyofpatientswithschizophrenia
AT gabrielsusan patientperspectiveoftheimpactofmedicationsideeffectsonadherenceresultsofacrosssectionalnationwidesurveyofpatientswithschizophrenia
AT dupclayleon patientperspectiveoftheimpactofmedicationsideeffectsonadherenceresultsofacrosssectionalnationwidesurveyofpatientswithschizophrenia
AT guptashaloo patientperspectiveoftheimpactofmedicationsideeffectsonadherenceresultsofacrosssectionalnationwidesurveyofpatientswithschizophrenia
AT kimedward patientperspectiveoftheimpactofmedicationsideeffectsonadherenceresultsofacrosssectionalnationwidesurveyofpatientswithschizophrenia